"332-bed Hospital, 24-hour Emergency Room, Lab Services, Cancer Services, Heart and Vascular Services, Inpatient and Outpatient Surgery, Rehabilitation Hospital, Imaging Services"

During the past decade, Roper St. Francis Healthcare conducted 25 clinical trials. In the 10-year time frame, 25 clinical trials started and 14 clinical trials were completed, i.e. on average, 56% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 10 clinical trials were completed. i.e. 250% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Roper St. Francis Healthcare" #1 sponsor was "University of Southern California" with 6 trials, followed by "Biogen" with 2 trials sponsored, "Eisai Inc." with 2 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored and "Otsuka Pharmaceutical Development & Commercialization, Inc." with 2 trials sponsored. Other sponsors include 15 different institutions and companies that sponsored additional 25 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Roper St. Francis Healthcare" #1 collaborator was "National Institute on Aging (NIA)" with 9 trials as a collaborator, "Alzheimer's Therapeutic Research Institute" with 7 trials as a collaborator, "Northern California Institute of Research and Education" with 3 trials as a collaborator, "Alzheimer's Association" with 2 trials as a collaborator and "Alzheimer's Clinical Trials Consortium" with 2 trials as a collaborator. Other collaborators include 18 different institutions and companies that were collaborators in the rest 25 trials.

According to Clinical.Site data, the most researched conditions in "Roper St. Francis Healthcare" are "Alzheimer's Disease" (13 trials), "Agitation in Patients With Dementia of the Alzheimer's Type" (2 trials), "Alzheimer Disease" (2 trials), "Alzheimer's Disease (AD)" (2 trials) and "Dementia" (2 trials). Many other conditions were trialed in "Roper St. Francis Healthcare" in a lesser frequency.

Most popular intervention types in "Roper St. Francis Healthcare" are "Drug" (27 trials), "Biological" (3 trials), "Device" (3 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (15 trials), "AVP-786" (2 trials), "Lecanemab" (2 trials), "placebo" (2 trials) and "AVB-620" (1 trials). Other intervention names were less common.

The vast majority of trials in "Roper St. Francis Healthcare" are 32 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Roper St. Francis Healthcare". undefined are not yet recruiting, 5 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 21 completed trials in Roper St. Francis Healthcare, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Roper St. Francis Healthcare, 0 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".

Roper St. Francis Healthcare has several departments that took part in Clinical trials: "Lowcountry Hematology Oncology PA-Mount Pleasant" - 44 trials, "Roper St. Francis Cancer Center at Roper Hospital" - 30 trials, "Charleston Oncology - Saint Francis" - 21 trials